Takeda Pharmaceutical Company Limited TAK
21.02 USD -0.17 (-0.80%)
At closeNov 6, 2026, 4:00 PM EST
21.74 +0.72 +3.43%
After hours · Nov 6, 4:00 PM ET
20.59 Day range 21.09
13.56 52-week range 21.73
- YTD
- +34.83%
- 1 year
- +54.11%
Revenue & Expenses
Latest period ending Mar 31, 2026 · select a line to chart its full history
Income statement
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 4.51T | 4.58T | 4.26T | 4.03T | 3.57T | |
| 2.93T | 3.00T | 2.84T | 2.78T | 2.46T | |
| 6.22B | 342.59B | 214.08B | 490.51B | 460.85B | |
| -152.39B | 107.93B | 144.07B | 317.02B | 230.06B | |
| -48.38 | 33.62 | 45.58 | 100.97 | 72.94 |
Balance sheet
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 595.05B | 385.11B | 457.80B | 533.53B | 849.70B | |
| 15.51T | 14.25T | 15.11T | 13.96T | 13.18T | |
| 8.08T | 7.31T | 7.83T | 7.60T | 7.49T | |
| 5.59T | 5.29T | 5.68T | 5.10T | 5.01T | |
| 7.43T | 6.94T | 7.27T | 6.35T | 5.68T |
Cash flow
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 1.04T | 1.06T | 716.34B | 977.16B | 1.12T | |
| -369.14B | -367.06B | -463.86B | -607.10B | -198.13B | |
| -496.82B | -751.42B | -354.42B | -709.15B | -1.07T | |
| -173.28B | -232.50B | -166.81B | -139.69B | -121.44B | |
| 175.47B | -61.30B | -101.93B | -339.09B | -145.28B |